BANGKOK, 21 April 2014 (NNT) – The National Science and Technology Development Agency (NSTDA) has said that for the first time, Thai researchers have developed their own anti-malaria drugs in Thailand.

Prof. Dr. Yongyuth Yuthavong, a senior researcher at NSTDA, says the researchers from National Center for Genetic Engineering and Biotechnology of Thailand (BIOTEC) have developed a new ‘P 218’ substance that can resist malaria.

Thai researchers applied the knowledge of a medicinal structure that had been found 10 years earlier, and used that to create the substance, which effectively resists malaria.

Read more: NNT